News

The Bartell Drugs at 1850 S. Mildred St. in Tacoma is on the latest Rite Aid store closure list. Bartell is a subsidiary of ...
More than 20 Washington stores added on back-to-back lists filed last week in bankruptcy court; four of those are in Pierce ...
The bulk are Rite Aid drugstores, except for four Bartell Drugs — one of those in Tacoma. The Seattle-based Bartell drugstore chain is a subsidiary of Rite Aid. Rite Aid at 12811 Meridian St. E., ...
Several reports mention the acquisition of prescription files by CVS Pharmacy, the closing of the Bartell Drugs Distribution Center in Des Moines, and the transition of some store locations to CVS ...
Peninsula Daily News on MSN5d
Rite Aid stores are set to close
Rite Aid at 520 W. Washington St. in Sequim will close June 26, according to signage and staff. Prescriptions will be transferred to QFC, 990 E. Washington St., Building B, in Sequim, by the closing ...
Apple Valley’s remaining Rite Aid has been added to the growing list of store closures as the company continues to sell off its remaining assets.
Italy’s referendums aimed at relaxing citizenship laws and improving job protections have failed on because of low turnout.
Getty Images is facing off against artificial intelligence company Stability AI in a London courtroom for the first major ...
Alex Zhavoronkov, founder & CEO of Insilico Medicine, stated that he “firmly believes that the repurposing of FDA-approved drugs with demonstrated anti-ageing potential represents a highly ...
It doesn’t identify dietary supplements (for example, most vitamins and herbals), illegal drugs, or drugs from outside the United States. The pill’s color Its shape Its imprint code (the text ...
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The ...
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies.